CAS: 1313706-14-7 - Pinatuzumab vedotin
Fórmula:Unspecified
- Sinónimos:
- FCU 2703
- Immunoglobulin G1, anti-(human antigen CD22) (human-Mus musculus monoclonal MCDT2219A heavy chain), disulfide with human-Mus musculus monoclonal MCDT2219A κ-chain, dimer, thioether with maleimidocaproyl-valine-citrulline-p-aminobenzyloxycarbonyl monomethylauristatin E
- RO 5541072-000
- Immunoglobulin G1, anti-(human sialic acid-binding immunoglobulin-like lectin 2) (human-Mus musculus monoclonal MCDT2219A heavy chain), disulfide with human-Mus musculus monoclonal MCDT2219A κ-chain, dimer, thioether with N-[[[4-[[N-[6-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-1-oxohexyl]-L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-N-methyl-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide
- Pinatuzumab vedotin
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Pinatuzumab vedotin REF: TM-T9901A-029CAS: 1313706-14-7 | - - - | A consultar | Mar 15 Oct 24 |
 | Pinatuzumab REF: 3D-CLA1324CAS: 1313706-14-7 | - - - | A consultar | Mié 23 Oct 24 |
Ref: TM-T9901A-029
| 1mg | A consultar | ||
| 5mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 15 de Octubre de 2024
Ref: 3D-CLA1324
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 23 de Octubre de 2024
